EP3746047
Inndælanleg samsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.6.2019EP published:
13.10.2021EP application number:
19733972.4
EP translation filed:
30.11.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
11.6.2039Expiry date:
11.6.2026Next due date:
30.6.2026
Title:
INJECTABLE COMPOSITION
Timeline
Today
12.6.2019EP application
13.10.2021EP Publication
30.11.2021Translation submitted
15.1.2022Registration published
11.6.2026Expires
Owner
Name:
Laboratorios Farmacéuticos Rovi, S.A.Address:
C/ Julián Camarillo 35, 28037 Madrid, ES
Inventor
Name:
FRANCO RODRÍGUEZ, GuillermoAddress:
28037 Madrid, ES
Name:
GUTIERRO ADURIZ, IbonAddress:
28037 Madrid, ES
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
18382413Date:
12.6.2018Country:
EP
Classification
Categories:
A61K 9/00, A61K 31/4196, A61K 47/34
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 13.6.2022
Expires: 11.6.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 5
Paid: 15.6.2023
Expires: 11.6.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 6
Paid: 11.6.2024
Expires: 11.6.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 10.6.2025
Expires: 11.6.2026
Payer: G.H. Sigurgeirsson ehf.